Cellebrite(NASDAQ) CLBT

Cellebrite DI Ltd. specializes in digital intelligence solutions tailored for legally authorized investigations. The company offers a comprehensive platform that enables efficient gathering, analysis, and management of digital information across various investigative scenarios.

Products and Services

• Universal Forensic Extraction Device (UFED) for accessing digital evidence
• Seeker for video footage analysis
• OSINT Analyze for real-time open-source information examination

Growth Outlook

• Revenue increased to $131.14 million in Q2 2026, up from $128.30 million in Q1 2026
• Net income rose to $6.37 million in Q2 2026, reflecting strong operational performance
• Trailing twelve months (TTM) gross profit margin stands at 82.96%, indicating robust profitability

Financial Highlights

• Operating income of $7.63 million in Q2 2026, showcasing effective cost management
• Cash and short-term investments totaled $442.53 million as of June 30, 2026
• Net income margin of 4.86% in Q2 2026, demonstrating consistent profitability

Cellebrite DI Ltd. operates in a critical sector, providing essential tools for law enforcement and corporate security. The company's innovative products, such as the UFED, address significant challenges in digital evidence collection, making it a vital partner for various governmental and enterprise clients. Recent financial performance indicates a positive trajectory, with increasing revenues and net income, reflecting strong demand for its solutions. The company's solid cash position further supports its growth potential, allowing for continued investment in research and development. As digital investigations become increasingly complex, Cellebrite's expertise positions it well for future opportunities in the expanding digital intelligence market.